BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 10179910)

  • 21. Medicare HMO risk contracts: background, problems, and prognosis.
    Krasner WL; Goff AR
    J Med Pract Manage; 1987; 3(2):128-33. PubMed ID: 10302093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of S/HMO disenrollees and continuing members.
    Harrington C; Newcomer RJ; Preston S
    Inquiry; 1993; 30(4):429-40. PubMed ID: 8288405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conducting research on the Medicare market: the need for better data and methods.
    Wong HS; Hellinger FJ
    Health Serv Res; 2001 Apr; 36(1 Pt 2):291-308. PubMed ID: 11327178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospice use in Medicare managed care and fee-for-service systems.
    Virnig BA; Fisher ES; McBean AM; Kind S
    Am J Manag Care; 2001 Aug; 7(8):777-86. PubMed ID: 11519237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health plan enrollment and mortality in the Medicare program.
    Dowd B; Maciejewski ML; O'Connor H; Riley G; Geng Y
    Health Econ; 2011 Jun; 20(6):645-59. PubMed ID: 20568081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medicare, managed care, and vision services to the elderly.
    Soroka M
    Med Interface; 1995 Jun; 8(6):118-22, 125, 141. PubMed ID: 10142941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do Medicare HMOs still reduce health services use after controlling for selection bias?
    Mello MM; Stearns SC; Norton EC
    Health Econ; 2002 Jun; 11(4):323-40. PubMed ID: 12007164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of a change in Medicare reimbursement policy and HEDIS measures on stage at diagnosis among Medicare HMO and fee-for-service female breast cancer patients.
    Habermann EB; Virnig BA; Riley GF; Baxter NN
    Med Care; 2007 Aug; 45(8):761-6. PubMed ID: 17667310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disenrollment from an HMO and its relationship with the characteristics of Medicare beneficiaries.
    Meng YY; Gocka IT; Leung KM; Elashoff RM; Legorreta AP
    J Health Care Finance; 1999; 26(2):53-60. PubMed ID: 10605663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disenrollment from Medicare HMOs.
    Call KT; Dowd BE; Feldman R; Lurie N; McBean MA; Maciejewski M
    Am J Manag Care; 2001 Jan; 7(1):37-51. PubMed ID: 11209449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-level cost of home health care under capitated and fee-for-service payment.
    Schlenker RE; Shaughnessy PW; Hittle DF
    Inquiry; 1995; 32(3):252-70. PubMed ID: 7591040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Policy implications of risk selection in Medicare HMOs: is the federal payment rate too high?
    Issue Brief Cent Stud Health Syst Change; 1996 Nov; (4):1-7. PubMed ID: 10539724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inpatient utilization by dual Medicare-Medicaid eligibles in Medicare risk HMOs and fee for service, California, 1991-1996.
    Sloss EM; Dhanani N; O'Leary JF; Lopez MS; Melnick G
    Manag Care Interface; 2004 Dec; 17(12):30-4, 41. PubMed ID: 15656377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health plan satisfaction and risk of disenrollment among social/HMO and fee-for-service recipients.
    Newcomer R; Preston S; Harrington C
    Inquiry; 1996; 33(2):144-54. PubMed ID: 8675278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disability outcomes of older Medicare HMO enrollees and fee-for-service Medicare beneficiaries.
    Porell FW; Miltiades HB
    J Am Geriatr Soc; 2001 May; 49(5):615-31. PubMed ID: 11380756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association of Medicare health care delivery systems with stage at diagnosis and survival for patients with melanoma.
    Kirsner RS; Wilkinson JD; Ma F; Pacheco H; Federman DG
    Arch Dermatol; 2005 Jun; 141(6):753-7. PubMed ID: 15967922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of mortality and intermediate outcomes between medicare dialysis patients in HMO and fee for service.
    Eggers PW; Frankenfield DL; Greer JW; McClellan W; Owen WF; Rocco MV
    Am J Kidney Dis; 2002 Apr; 39(4):796-804. PubMed ID: 11920346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing Medicare enrollment in HMOs: the need for capitation rates adjusted for health status.
    Thomas JW; Lichtenstein R; Wyszewianski L; Berki SE
    Inquiry; 1983; 20(3):227-39. PubMed ID: 6226608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of HMOs on fee-for-service health care expenditures: evidence from Medicare revisited.
    Batata A
    J Health Econ; 2004 Sep; 23(5):951-63. PubMed ID: 15353188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A closer look at the managed care backlash.
    Cooper PF; Simon KI; Vistnes J
    Med Care; 2006 May; 44(5 Suppl):I4-11. PubMed ID: 16625063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.